Topamax Birth Defects

Many People today suffer from epilepsy and lots of new cases are diagnosed each year. Topamax is one of the many anticonvulsant drugs prescribed by doctors to treat the symptoms associated with epilepsy, and was originally approved by the FDA in 1996 for this purpose. Topamax was likewise approved for cure for migraine headaches in 2004, and has since become one of the most widely used forms of anticonvulsant medicines on the market. Topamax’s active ingredient, topiramate, is used alone or in combination with other anti-seizure medications to be able to prevent migraines and seizures associated with epilepsy. Unfortunately, the latest research has indicated a potential connection between Topamax use and the development of major birth defects in infants who are subjected to the drug in utero. Studies have shown a significantly increased risk of facial malformations, like cleft lip and cleft palate, and also genital deficiencies in small children whose mothers take on the topiramate-containing Topamax while pregnant. Visit Topamax Birth Defects for more information.